Application of a combined effect compartment and binding model for gastric acid inhibition of AR-HO47108: A potassium competitive acid blocker, and its active metabolite AR-HO47116 in the dog-Reference-Cited by-同舟云学术

Application of a combined effect compartment and binding model for gastric acid inhibition of AR-HO47108: A potassium competitive acid blocker, and its active metabolite AR-HO47116 in the dog

Published:2006-10 Issue:2 Volume:29 Page:91-101
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Äbelö Angela,Andersson Magdalena,Holmberg Ann Aurell,Karlsson Mats O.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference16 articles.

1. Pharmacodynamic modelling of reversible gastric acid pump inhibition in dog and man;Äbelö;Eur. J. Pharm. Sci.,2001

2. NONMEM User's Guide NONMEM Project Group;Beal,1992

3. Comparison of four basic models of indirect pharmacodynamic responses;Dayneka;J. Pharmacokinet. Biopharm.,1993

4. Models of schedule dependent haematological toxicity of 2′-deoxy-2′-methylidenecytidine (DMDC);Friberg;Eur. J. Clin. Pharmacol.,2000

5. Xpose—an S-Plus-based population pharmacokinetic/pharamacodynamic model building aid for NONMEM;Jonsson;Comput. Method Prog. Biomed.,1999

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacodynamic model of slow reversible binding and its applications in pharmacokinetic/pharmacodynamic modeling: review and tutorial;Journal of Pharmacokinetics and Pharmacodynamics;2022-08-30

2. Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases;Journal of Neurogastroenterology and Motility;2018-07-30

3. Modelling the delay between pharmacokinetics and EEG effects of morphine in rats: binding kinetic versus effect compartment models;Journal of Pharmacokinetics and Pharmacodynamics;2018-05-18

4. The influence of drug distribution and drug-target binding on target occupancy: The rate-limiting step approximation;European Journal of Pharmaceutical Sciences;2017-11

5. KFP-H008 blocks gastric acid secretion through inhibiting H+-K+-ATPase;European Journal of Pharmacology;2017-09